Canada Markets open in 6 hrs 12 mins

BioSyent Inc. (RX.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
7.270.00 (0.00%)
At close: 03:59PM EST
Full screen
Previous Close7.27
Bid7.21 x 0
Ask7.30 x 0
Day's Range7.27 - 7.32
52 Week Range6.24 - 10.00
Avg. Volume3,724
Market Cap91.456M
Beta (5Y Monthly)0.86
PE Ratio (TTM)25.07
EPS (TTM)0.29
Earnings DateMar 07, 2023 - Mar 13, 2023
Forward Dividend & Yield0.16 (2.28%)
Ex-Dividend DateNov 29, 2022
1y Target EstN/A
  • GlobeNewswire

    BioSyent Signs Exclusive Agreement for Oncology Supportive Care Product

    MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has signed an exclusive Distribution Agreement with a European partner for a product that is used in oncology supportive care. The product has been marketed in Europe, USA and several other markets around the world to help cancer patients with certain side effects of their treatment. BioSyent anticipates launching the

  • GlobeNewswire

    BioSyent Announces Renewal of Normal Course Issuer Bid

    MISSISSAUGA, Ontario, Dec. 13, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of Intention to Make a Normal Course Issuer Bid (the “NCIB”). Pursuant to the NCIB, BioSyent may purchase up to 690,000 of its common shares (“Shares”) over a 12-month period, representing approximately 5.70% of the Shares outstanding as of December 13, 2022. The NCIB will commence on De


    Stock Pitch World Cup(TM), Educational Panels and 49 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on December 6-8, 2022

    The Planet MicroCap Showcase: VIRTUAL taking place on December 6-8, 2022, where 49 MicroCap public companies will be presenting virtually.